XML 71 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation - Stock Options and Significant Valuation Assumptions (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
May 12, 2022
Mar. 30, 2024
Apr. 01, 2023
Mar. 26, 2022
Stock Options        
Granted   0   0
Employee Stock Option [Member]        
Stock Options        
Outstanding at the beginning of period   739,480    
Exercised   (398,875)    
Outstanding at the end of period   340,605 739,480  
Vested and expected to vest after end of period   340,605    
Exercisable at end of period   186,118    
Grant Date Weighted-Average Exercise Price        
Outstanding at the beginning of period   $ 31.60    
Exercise price (in dollars per share)   24.41    
Outstanding at the end of period   40.00 $ 31.60  
Vested and expected to vest at end of period   40.00    
Exercisable at end of period   $ 24.67    
Weighted Average Remaining Contractual Life        
Weighted average remaining contractual life, awards outstanding   5 years 6 months    
Weighted average remaining contractual life, awards vested and expected to vest   5 years 6 months    
Weighted average remaining contractual life, awards exercisable   4 years 3 months 18 days    
Aggregate Intrinsic Value        
Aggregate intrinsic value, awards exercised   $ 26,774    
Aggregate intrinsic value, awards outstanding   18,783    
Aggregate intrinsic value, awards vested and expected to vest   18,783    
Aggregate intrinsic value, awards exercisable   $ 13,117    
CEO | 2020 Plan        
Assumptions used        
Stock price (in dollars per share) $ 86.96      
Exercise price (in dollars per share) $ 86.96   $ 86.96  
Expected option term 6 years 6 months      
Expected volatility factor 65.90%      
Risk-free interest rate 2.80%      
Expected annual dividend yield 0.00%      
Stock Options        
Granted     86,189